Commentary Open Access
Volume 2 | Issue 4 | DOI: https://doi.org/10.33696//immunology.2.035
Autoantibodies in Overlapping Systemic Sclerosis and Primary Biliary Cirrhosis Autoimmune Diseases
Manuel M. Valdivia1,*
- 1Department of Biomedicine, Biotechnology and Public Health, Faculty of Sciences, University of Cádiz, 11510 Puerto Real, Cádiz, Spain
Corresponding Author
Manuel M. Valdivia, manuel.valdivia@uca.es
Received Date: April 12, 2020
Accepted Date: May 26, 2020
Valdivia MM. Autoantibodies in Overlapping Systemic Sclerosis and Primary Biliary Cirrhosis Autoimmune Diseases. J Cell Immunol. 2020; 2(4): 165-167.
Copyright: © 2020 Valdivia MM. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Autoantibodies in Overlapping Systemic Sclerosis and Primary Biliary Cirrhosis Autoimmune Diseases
Anticentromere antibodies (ACA) are considered an important diagnostic marker of scleroderma or systemic sclerosis (SSc), being CENP-B the major centromere auto-antigen recognized by sera from SSc patients. However, ACA can also be detected in patients with other connective tissue diseases. Significantly the prevalence of organ-specific antibodies in SSc patients is relatively high.
The Long-COVID Syndrome: Neoantigens as Driving Force for the Onset of Autoimmune Diseases
In the fifth year of the pandemic, SARS-CoV-2 variants continue to unveil new insights into particular mechanism of human immunology but also new clues on the interaction of SARS-CoV-2 proteins with host proteins. Nearly all yet known SARS-CoV-2 variants had the ability to cause a post-infection disease termed the Long COVID (LC) syndrome